(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1587486

北米のOTC健康製品の市場規模、シェア、動向分析：用途別、形態別、製品別、デモグラフィ別、流通チャネル別、およびセグメント別予測、2025年～2030年

North America OTC Health Products Market Size, Share & Trends Analysis By Application (Digestive Health, Women's Health), By Form (Liquid, Gummies), By Product, By Demography, By Distribution Channel, And Segment Forecasts, 2025 - 2030
PrevNext
1
2
3
4

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
北米のOTC健康製品の市場規模、シェア、動向分析：用途別、形態別、製品別、デモグラフィ別、流通チャネル別、およびセグメント別予測、2025年～2030年
出版日: 2024年10月28日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
PrevNext
1
2
3
4
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のOTC健康製品市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、北米のOTC健康製品市場規模は、2025年から2030年にかけてCAGR 6.15%で拡大し、2030年には1,066億1,000万米ドルに達する見込みです。

消費者の意識の高まりと栄養補助食品への支出意欲の高まり、肥満や糖尿病を含む生活習慣病の有病率の上昇、可処分所得の増加、OTC製品の流通チャネルの増加が、成長を促進する主な要因の一部です。消費者は、健康的なライフスタイルの維持に役立つ栄養補助食品の利点を実感するようになっており、市場成長にプラスの影響を与えています。米国国立衛生研究所（National Institute of Health）によると、米国人は減量用の栄養補助食品（通常は錠剤）に年間約21億米ドルを費やしています。

eコマースの出現により、栄養補助食品へのアクセスが増加しています。オンラインチャネル以外では、General Nutrition Centers, Inc.、Walmart、Vitamin Shoppeなどの企業が主な小売店です。このように、これらの製品を簡単に入手できることは、この分野の主要プレーヤーに成長機会を提供します。さらに、癒し効果があり、精神作用がほとんどないCBDへの消費者の嗜好の変化は、CBD入り製品の成長の可能性を促進すると予想されます。ギャラップ社の2019年の報告によると、米国では個人の約14％が何らかの形でCBD入り製品を使用したことがあります。成人の約58％が痛み関連の症状に、約42％が精神衛生関連の症状に使用しています。

COVID-19の大流行により、免疫力を高めるサプリメントに対する消費者の嗜好が急増しました。スポーツ栄養、女性・男性用健康食品などの分野では、パンデミックを抑制するために政府が行った規制によりマイナスの影響が見られました。COVID-19の影響は2020年第3四半期以降減少し、市場の回復に寄与しました。

市場は多数の企業が存在するため断片化されており、競争企業間の敵対関係が激化しています。各社は複数の提携やM&Aを行い、ポートフォリオを拡大し、全国に拠点を広げています。さらに、各社はより大きな市場シェアを獲得するため、製品の差別化やバンドル戦略に注力しています。例えば、CVサイエンシズ社は2022年3月にPlusCBD Relief Softgelsを発売しました。同社は、生の処方よりも7倍優れたカンナビジオール酸（CBDA）とカンナビジオール（CBD）を供給できると主張しています。この製品は炎症反応の治療に臨床的意義があります。

北米OTC健康製品市場レポートハイライト：

  • 栄養補助食品と減量製品セグメントは2024年に33.71%のシェアを占めました。この背景には、健康的な食生活の利点に関する消費者の意識の高まり、自己健康意識の高まり、肥満の有病率の上昇があります。
  • スポーツ製剤セグメントは、フィットネスに関する意識の高まりとスポーツ栄養の高い商業的利用可能性により、2024年に22.24％の最大シェアを占めました。
  • 成人層向けの多種多様なOTC製品が入手可能であることから、予測期間中は成人向け分野が最も急成長すると予測されます。
  • 2024年には、ハイパーマーケット、スーパーマーケット、コンビニエンスストアが市場を独占します。
  • 2024年には、カプセルと錠剤のセグメントが市場を独占しました。これは、市場でカプセル＆錠剤形態の製品が広く入手可能であること、カプセル＆錠剤の送達形態を強化する技術革新が増加していること、保存可能期間が長いことなどに起因しています。
  • 米国は、主要企業の存在、慢性疾患と肥満の有病率の増加、老年人口の急速な増加などを主因として、収益面で市場を独占しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 北米のOTC健康製品市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • 北米のOTC健康製品市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 北米のOTC健康製品市場：製品の推定・動向分析

  • セグメントダッシュボード
  • 北米のOTC健康製品市場：製品変動分析
  • 北米のOTC健康製品市場：製品別展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • 咳止め、風邪、インフルエンザ対策製品
    • 液体
    • カプセル/錠剤
    • グミ
    • その他
  • 栄養補助食品と減量製品
    • 液体
    • カプセル/錠剤
    • グミ
    • その他
  • スポーツ栄養製品
    • 液体
    • カプセル/錠剤
    • グミ
    • その他
  • プロバイオティクス
    • 液体
    • カプセル/錠剤
    • グミ
    • その他
  • CBD栄養補助食品
    • 液体
    • カプセル/錠剤
    • グミ
    • その他

第5章 北米のOTC健康製品市場： 形態の推定・動向分析

  • セグメントダッシュボード
  • 北米のOTC健康製品市場：形態の変動分析
  • 北米のOTC健康製品市場形態別展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • 液体
  • カプセル/錠剤
  • グミ
  • その他

第6章 北米のOTC健康製品市場：用途の推定・動向分析

  • セグメントダッシュボード
  • 北米のOTC健康製品市場：用途変動分析
  • 北米のOTC健康製品市場、用途別展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • 消化器系の健康
  • 女性と男性の健康
  • 体重管理
  • 関節の健康
  • 免疫防御
  • スポーツフォーミュレーション
  • その他

第7章 北米のOTC健康製品市場：デモグラフィの推定・動向分析

  • セグメントダッシュボード
  • 北米のOTC健康製品市場：デモグラフィ分析
  • 北米のOTC健康製品市場、デモグラフィ別の展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • 子供
  • 大人

第8章 北米のOTC健康製品市場：流通チャネルの推定・動向分析

  • セグメントダッシュボード
  • 北米のOTC健康製品市場：流通チャネル変動分析
  • 北米のOTC健康製品市場：流通チャネル別の見通し
  • 2018年から2030年までの市場規模と予測および動向分析
  • 小売薬局
  • オンライン
  • 大型スーパーマーケット、スーパーマーケット、コンビニエンスストア
  • その他

第9章 北米のOTC健康製品市場：地域の推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測動向分析、2018年から2030年：
  • 北米
    • 米国
    • カナダ
    • メキシコ

第10章 競合情勢

  • 市場参入企業の分類
  • 主要市場参入企業による最近の動向と影響分析
  • 企業市場シェア分析、2024年
  • 主要企業プロファイル
    • Herbalife Nutrition
    • CV Sciences, Inc.
    • Medical Marijuana Inc.
    • Nature's Sunshine Products Inc.
    • Johnson and Johnson Services, LLC
    • GlaxoSmithKline Inc.
    • Bayer AG
    • American Health
    • THE BOUNTIFUL COMPANY（Nestle Health Science SA）
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 4. North America OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 5. North America OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 6. North America OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 7. North America OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 8. U.S. OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 9. U.S. OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 10. U.S. OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 11. U.S. OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 12. U.S. OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 13. Canada OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 14. Canada OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 15. Canada OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 16. Canada OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 17. Canada OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 18. Mexico OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 19. Mexico OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 20. Mexico OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 21. Mexico OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 22. Mexico OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research approaches
  • Fig. 2 Value chain-based sizing & forecasting
  • Fig. 3 Market formulation & validation
  • Fig. 4 North America OTC Health Products market segmentation
  • Fig. 5 Market driver analysis (current & future impact)
  • Fig. 6 Market restraint analysis (current & future impact)
  • Fig. 7 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 8 Porter's five forces analysis
  • Fig. 9 North America OTC health products market: Product outlook and key takeaways
  • Fig. 10 North America OTC health products market: Product movement analysis
  • Fig. 11 Cough, cold, and flu products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 12 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 13 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 14 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 15 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 16 Dietary supplements and weight loss products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 17 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 18 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 19 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Sports nutrition products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Probiotics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 CBD nutraceutical products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 North America OTC health products market: Application outlook and key takeaways
  • Fig. 37 North America OTC health products market: Application movement analysis
  • Fig. 38 Digestive health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 39 Women's & men's health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 Weight control market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Joint health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Immune defense market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 Sports formulation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 North America OTC health products market: Form outlook and key takeaways
  • Fig. 46 North America OTC health products market: Form movement analysis
  • Fig. 47 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Capsules & tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Gummy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 North America OTC health products market: Distribution channel outlook and key takeaways
  • Fig. 52 North America OTC health products market: Distribution channel movement analysis
  • Fig. 53 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 Online market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Hypermarkets, supermarkets, convenience stores market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 North America OTC health products market: Demography outlook and key takeaways
  • Fig. 58 North America OTC health products market: Demography movement analysis
  • Fig. 59 Children market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Adults market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 North America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 US market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 64 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 65 List of key emerging company's/disruptors/innovators
目次
Product Code: GVR-4-68039-951-7

North America OTC Health Products Market Growth & Trends:

The North America OTC health products market size is expected to reach USD 106.61 billion by 2030, expanding at a CAGR of 6.15% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising consumer awareness and increasing consumer willingness to spend on nutritional supplements, the increasing prevalence of lifestyle diseases including obesity & diabetes, rise in disposable income, and an increase in the number of distribution channels for OTC products are some of the key factors driving growth. Consumers are increasingly realizing the benefits of nutritional supplements, which help them sustain a healthy lifestyle, thereby positively impacting the market growth. According to the National Institute of Health, Americans spend around USD 2.1 billion annually on weight-loss dietary supplements, usually in the form of pills.

The emergence of e-commerce has led to increased accessibility to dietary and nutritional supplements. Apart from the online channels, companies such as General Nutrition Centers, Inc.; Walmart; and Vitamin Shoppe are some of the major retail outlets. Thus, the easy availability of these products will provide growth opportunities to key players in this space. Moreover, shifting consumer preference to CBD due to its healing properties and limited to no psychoactive effects is expected to drive the growth potential for CBD-infused products. According to Gallup, Inc. report of 2019, approximately 14% of individuals in the U.S. have used some or the other form of CBD-infused products. About 58% of adults use it for pain-related conditions and around 42% for mental health-related conditions.

The COVID-19 pandemic resulted in a surge in consumer preference for immunity-boosting supplements. Segments such as sports nutrition, and women's & men's health saw a negative impact due to lockdowns imposed by governments to curb the pandemic. The effect of COVID-19 declined post the third quarter of 2020, which helped the market regain traction.

The market is fragmented with the presence of a large number of companies, intensifying the overall competitive rivalry. Companies are undertaking multiple partnerships and mergers & acquisitions to increase their portfolio & expand their footprint across the country. In addition, companies are focusing on product differentiation and bundling strategies to capture a greater market share. For instance, in March 2022, CV Sciences, Inc. launched PlusCBD Relief Softgels. The company claims that it can deliver seven times better Cannabidiol Acid (CBDA) and Cannabidiol (CBD) than its raw formula. This product has clinical significance in the treatment of inflammatory responses.

North America OTC Health Products Market Report Highlights:

  • The dietary supplements and weight loss products segment accounted for 33.71% of the share in 2024. This is attributed to an increase in consumer awareness about the benefits of a healthy diet, growing self-health consciousness, and a rise in the prevalence of obesity
  • The sports formulation segment accounted for the largest share of 22.24% in 2024 due to rising awareness about fitness and high commercial availability of sports nutrition
  • Adults segment is projected to witness the fastest growth during the forecast period owing to the availability of a wide variety of OTC products for the adult demographic
  • Hypermarkets, supermarkets, and convenience stores dominated the market in 2024, owing to the better feasibility of buying from such places and an increase in the number of strategic initiatives like schemes such as loyalty programs
  • The capsules & tablets segment dominated the market in 2024. This can be attributed to the wide availability of products in capsule & tablet form in the market, the rise in innovation to enhance capsules & tablets delivery forms, and higher shelf-life
  • The U.S. dominated the market in terms of revenue, mainly due to the presence of key players, an increase in the prevalence of chronic diseases & obesity, and a rapidly growing geriatric population

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Form
    • 1.2.4. Demography
    • 1.2.5. Distribution Channel
    • 1.2.6. Country Scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Country outlook
  • 2.4. Competitive Insights

Chapter 3. North America OTC Health Products Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Consumer Demand for Self-Care
      • 3.2.1.2. Expansion of Product Offerings
      • 3.2.1.3. Aging Population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory Challenges
      • 3.2.2.2. Competition from Prescription Drugs
  • 3.3. North America OTC Health Products Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. North America OTC Health Products Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America OTC Health Products Market: Product Movement Analysis
  • 4.3. North America OTC Health Products Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Cough, Cold, and Flu Products
    • 4.5.1. Liquid
      • 4.5.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Capsules/Tablets
      • 4.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Gummies
      • 4.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Dietary Supplements and Weight Loss Products
    • 4.6.1. Liquid
      • 4.6.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Capsules/Tablets
      • 4.6.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Gummies
      • 4.6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Sports Nutrition Products
    • 4.7.1. Liquid
      • 4.7.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. Capsules/Tablets
      • 4.7.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. Gummies
      • 4.7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.4. Others
      • 4.7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Probiotics
    • 4.8.1. Liquid
      • 4.8.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.2. Capsules/Tablets
      • 4.8.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.3. Gummies
      • 4.8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.4. Others
      • 4.8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. CBD Nutraceutical Products
    • 4.9.1. Liquid
      • 4.9.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.2. Capsules/Tablets
      • 4.9.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.3. Gummies
      • 4.9.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.4. Others
      • 4.9.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America OTC Health Products Market: Form Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America OTC Health Products Market: Form Movement Analysis
  • 5.3. North America OTC Health Products Market by Form Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Liquid
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Capsules/Tablets
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Gummies
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America OTC Health Products Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. North America OTC Health Products Market: Application Movement Analysis
  • 6.3. North America OTC Health Products Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Digestive health
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Women's & Men's Health
    • 6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Weight Control
    • 6.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Joint health
    • 6.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Immune Defense
    • 6.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Sports Formulation
    • 6.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. North America OTC Health Products Market: Demography Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. North America OTC Health Products Market: Demography Movement Analysis
  • 7.3. North America OTC Health Products Market by Demography Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Children
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Adults
    • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. North America OTC Health Products Market: Distribution Channel Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. North America OTC Health Products Market: Distribution Channel Movement Analysis
  • 8.3. North America OTC Health Products Market by Distribution Channel Outlook (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5. Retail pharmacies
    • 8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Online
    • 8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Hypermarkets, supermarkets, convenience stores
    • 8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Others
    • 8.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. North America OTC Health Products Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Recent Developments & Impact Analysis by Key Market Participants
  • 10.3. Company Market Share Analysis, 2024
  • 10.4. Key Company Profiles
    • 10.4.1. Herbalife Nutrition
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. CV Sciences, Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Medical Marijuana Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Nature's Sunshine Products Inc.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Johnson and Johnson Services, LLC
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. GlaxoSmithKline Inc.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Bayer AG
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. American Health
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. THE BOUNTIFUL COMPANY (Nestle Health Science S.A.)
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives